公司资料
Sensei Biotherapeutics 股价、新闻与催化剂
- 股票代码:
- SNSE
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
13.85 USD (+6.54%)
收盘价
最后更新: 2026年6月15日
21.6M USD
市值
股价为何变动
Current closing-price context is not available for SNSE.
公司概览
业务概览
Sensei Biotherapeutics is an immuno-oncology company focused on activating the immune system against cancer. Its platform aims to create differentiated cancer treatments through immune modulation.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Sensei sits in specialty oncology biotechnology.
商业模式特征
The company depends on clinical data, immune-mechanism validation, and the ability to build a durable cancer franchise.
生物医药行业定位
Sensei is a catalyst-driven immuno-oncology name whose stock responds to early clinical and translational progress.
未来催化剂
- The cleaner way to frame Sensei Biotherapeutics right now is around its latest development priorities. The most useful line from the latest update is First patient dosed in Phase 1b/2 trial of PIKTOR in HR+/HER2- advanced breast cancer Topline Phase 2 data in patients with advanced endometrial cancer expected in second half.... That should keep the program at the center of the company narrative for now.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。